Article
MiR-29a is a candidate biomarker of better survival in metastatic high-grade serous carcinoma.
Human pathology - 1 Aug 2016
Nymoen Dag Andre, Slipicevic Ana, Holth Arild, Emilsen Elisabeth, Hetland Falkenthal Thea E, Tropé Claes G, Reich Reuven, Flørenes Vivi Ann, Davidson Ben
Abstract excerpt
The objective of this study was to analyze the clinical role of 9 microRNAs (miRs) previously found to be overexpressed in ovarian carcinoma effusions compared with primary ovarian carcinomas. High-grade serous carcinoma effusions (n=148) were analyzed for expression of miR-29a, miR-31, miR-99b, miR-182, miR-210, miR-221, miR-222, miR-224, and miR-342 using quantitative polymerase chain reaction. Expression...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.